Clinical Trial Update: Lemborexant Treatment of Insomnia Linked to Epilepsy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating lemborexant for insomnia linked to epilepsy; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Insomnia

Drugs mentioned

• Lemborexant (lemborexant)

Snippet

Sponsor: University of Manitoba | Conditions: Epilepsy, Sleep | Phase 3 | Status: RECRUITING